Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference31 articles.
1. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma;WD Travis;J Thorac Oncol,2011
2. Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratoy Society classification;WD Travis;Arch Pathol Lab Med,2013
3. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases;A Yoshizawa;Mod Pathol,2011
4. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification;PA Russell;J Thorac Oncol,2011
5. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival;A Warth;J Clin Oncol,2012
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming;Nature;2023-07-19
2. Deep learning‐based classification and spatial prognosis risk score on whole‐slide images of lung adenocarcinoma;Histopathology;2023-04-18
3. Transcriptional patterns reveal tumor histologic heterogeneity and immunotherapy response in lung adenocarcinoma;Frontiers in Immunology;2022-08-08
4. Therapeutic targeting of macrophage plasticity remodels the tumor-immune microenvironment;Cancer Research;2022-06-16
5. A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma;Genome Medicine;2022-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3